The global intravenous immunoglobulin market is likely to witness considerable growth driven by recent molecular advancements. According to a report published by Fortune Business Insights, titled “Intravenous Immunoglobulin Industry Size, Share & Industry Analysis By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Regional Forecast, 2018 – 2025,” the was valued at USD 9,787.6 Million in 2017 and is projected to reach USD 15,789.1 Million by 2025 exhibiting a CAGR of 6.2% in the forecast period (2018-2025).
Some of the leading companies that are operating in the market are:
- Shire (Takeda Pharmaceutical Company Limited)
- CSL Behring
- Grifols, S.A.
- Kedrion S.p.A
- Bio Products Laboratory Ltd.
- Biotest AG
- China Biologic Products Holdings, Inc.
- LFB SA
- Shanghai RAAS Blood Products Co., Ltd.
Increasing Adoption of Immunoglobulins to Help Asia Pacific Register Fastest Growth
According to the report, The Global Intravenous Immunoglobulin Industry was dominated by North America with a market value of US$ 5,587.4 Mn in 2017. The region is likley to remain dominant through the forecast period as well due to the presence of first line treatment for critical immune disorders. Other factors boosting the market in the region are rising number of patients and efficient results of the intravenous immunoglobulin treatment.
On the other side, the market in Asia Pacific is anticipated to grpow at faster rate in the coming years on account of the rise in awareness about the treatment option avaiulable for immunologic deficiencies. In addition to this, the rise in adoption and expenditure of immunoglobulins in economies such as Japan, China,and Indiais anticipated to boost the market in the region.
- Primary Immunodeficiency
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Guillain-Barré Syndrome (GBS)
- Immune Thrombocytopenic Purpura (ITP)
- Multifocal Motor Neuropathy (MMN)
By End User
- North America (the U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America
- Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
Some major points from Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1. Pipeline Analysis
4.2. Overview of Regulatory Scenario by Key Regions
4.3. Key Industry Developments
4.4. Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries
4.5. Overview of Reimbursement Scenario
- Global Intravenous Immunoglobulin Industry Analysis, Insights and Forecast, 2015-2025
5.1. Key Findings /Summary
5.2. Market Analysis, Insights and Forecast – By Indication
5.2.1. Primary Immunodeficiency
5.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.2.3. Guillain-Barré Syndrome (GBS)
5.2.4. Immune Thrombocytopenic Purpura (ITP)
5.2.5. Multifocal Motor Neuropathy (MMN)
5.3. Market Analysis, Insights and Forecast – By Form
5.4. Market Analysis, Insights and Forecast – By End User
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
- North America Market Analysis,Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Indication
6.2.1. Primary Immunodeficiency
6.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
6.2.3. Guillain-Barré Syndrome (GBS)
6.2.4. Immune Thrombocytopenic Purpura (ITP)
6.2.5. Multifocal Motor Neuropathy (MMN)
6.3. Market Analysis – By Form
6.4. Market Analysis – By End User
6.5. Market Analysis – By Country
More Trending Topics From Fortune Business [email protected]
Global Peritoneal Dialysis Market Size, Share & Growth 2025
Dental Implants Market Size, Share & Growth Analysis 2026
Genomics Market Size, Growth, Trends | Analysis Report, 2026
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
Linkedin | Twitter | Blogs